ÂÜÀòÂÒÂ×

Y-mAbs Therapeutics

0 followers
‌

Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

Industries

Employees

51-200

Links


Org chart

Thomas Gad
Chairman & CEO
Collapse
Joris Wilms
SVP & COO
Sune Nyland
VP, General Counsel
Peter Pfreundschuh
Chief Financial Officer
Sue Smith
SVP, CCO
Norman LaFrance
Chief Development Officer, Y-mAbs Therapeutics, Inc
Doug Gentilcore
Senior Vice President, Head of Danyleza Business Unit
Nancy Momcilovic
Executive Administrator

Board & advisors

Johan Wedell-Wedellsborg
Majority shareholder / Boardmember
David N. Gill
Board member; chairman of audit committee